3 results
The primary objective of this study is to demonstrate whether the MiStent Drug Eluting Coronary Stent System can safely and effectively improve coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo…
The primary objective is to determine the effect of co-administration of telepravir, given as 2 tablets of 375 mg every 8 hours and DRV/rtv or fAPV/rtv on the amount of telaprevir and DRV/rtv or fAPV/rtv in the body. The secondary objective is to…
To investigate the feasibility of a newly proposed method with the non-invasive Optimedic dynamic neuromodulator for chronic low back pain patients. Stakeholders will be interviewed to objectify the feasibility of the methods used in this study.A…